- Home
- PRE vs TARA Comparison
PRE vs TARA Comparison
Compare PRE & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRE
- TARA
- Stock Information
- Founded
- PRE 2014
- TARA N/A
- Country
- PRE Hong Kong
- TARA United States
- Employees
- PRE N/A
- TARA N/A
- Industry
- PRE Biotechnology: Laboratory Analytical Instruments
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PRE Industrials
- TARA Health Care
- Exchange
- PRE Nasdaq
- TARA Nasdaq
- Market Cap
- PRE 60.2M
- TARA 52.4M
- IPO Year
- PRE N/A
- TARA N/A
- Fundamental
- Price
- PRE $4.50
- TARA $2.47
- Analyst Decision
- PRE Buy
- TARA Strong Buy
- Analyst Count
- PRE 1
- TARA 2
- Target Price
- PRE $9.00
- TARA $24.00
- AVG Volume (30 Days)
- PRE 5.3K
- TARA 235.4K
- Earning Date
- PRE 11-26-2024
- TARA 11-12-2024
- Dividend Yield
- PRE N/A
- TARA N/A
- EPS Growth
- PRE N/A
- TARA N/A
- EPS
- PRE N/A
- TARA N/A
- Revenue
- PRE $22,662,330.00
- TARA N/A
- Revenue This Year
- PRE $64.44
- TARA N/A
- Revenue Next Year
- PRE $154.24
- TARA N/A
- P/E Ratio
- PRE N/A
- TARA N/A
- Revenue Growth
- PRE N/A
- TARA N/A
- 52 Week Low
- PRE $2.85
- TARA $1.04
- 52 Week High
- PRE $7.84
- TARA $5.24
- Technical
- Relative Strength Index (RSI)
- PRE 48.01
- TARA 57.56
- Support Level
- PRE $4.43
- TARA $2.43
- Resistance Level
- PRE $4.88
- TARA $2.74
- Average True Range (ATR)
- PRE 0.23
- TARA 0.19
- MACD
- PRE 0.01
- TARA -0.00
- Stochastic Oscillator
- PRE 55.14
- TARA 45.23
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company, that is dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).